Integumen PLC - Exercise of Warrants; Total Voting Rights

RNS Number : 0356P
Integumen PLC
05 June 2020


AIM share code: SKIN

5 June 2020 

Integumen PLC


("Integumen" or "Company")



Exercise of Warrants


Integumen announces that it has received notification from a warrant holder to exercise warrants over 3,333,332 shares in the share capital of Integumen ("the Warrant Shares"). The consideration for the exercise of the Warrant Shares amounts, in aggregate, to a cash value of £49,999.98.


Total voting rights


The Warrant Shares were allotted on 4 June 2020. Application has been made for the Warrant Shares to be admitted to trading on AIM ("Admission"), and Admission is expected to be on or about 10 June 2020. These shares will rank pari passu with the ordinary shares of the Company in issue.


The Company's total issued share capital, following the issue of the Warrant Shares, will be 1,078,750,235 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.



Integumen plc

Gerard Brandon, CEO

+44 (0) 7340 055 648




SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974




Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050





About Integumen plc:

Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Quick facts: Integumen

Price: 2.69

Market: AIM
Market Cap: £29.02 m

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Integumen's Gerry Brandon details new £3mln facility for Labskin and...

Integumen's (LON:SKIN) Gerry Brandon speaks to Proactive London's Andrew Scott after announcing they've secured a new £3mln three-year loan facility that requires no loan repayments until next year. He says the initial drawdown of £1.5mln provides them with sufficient working capital for its...

2 weeks, 3 days ago